
Loading, please wait...

Loading, please wait...

The development of usnic acid antifungal derivatives represents a significant step forward in addressing the growing challenge of fungal resistance. Researchers recently synthesized 40 novel compounds by modifying the natural lichen product usnic acid. This effort aimed to enhance potency and solubility while leveraging the unique dibenzofuran core for targeted antifungal action. Specifically, the team used active substructure splicing strategies to incorporate amino acid linkers and acylhydrazide substituents. Furthermore, the evaluation revealed that compound A24, containing a 3,4-difluorophenyl moiety, possesses exceptional antifungal properties.
Consequently, A24 exhibited significant efficacy against pathogens like Thanatephorus cucumeris and Alternaria solani. In pot experiments, A24 achieved a curative activity of 77.83%. Moreover, this efficacy surpassed the commercial standard thifluzamide. The team also investigated the underlying biochemical mechanisms. Interestingly, A24 suppressed the pathogen's antioxidant enzymes, such as peroxidase and catalase. This suppression leads to mitochondrial membrane potential disruption and eventual mycelial death. However, the researchers emphasize that A24 also maintains a favorable safety profile. Additionally, this study advances the development of natural product-derived fungicides for clinical and agricultural use. The novel structural scaffold provides a platform for future ROS-inducing antifungal agents.
These compounds work by disrupting cellular redox homeostasis. Specifically, they suppress antioxidant enzymes like peroxidase and catalase, leading to the accumulation of reactive oxygen species (ROS) and subsequent fungal cell death.
In pot experiments, A24 achieved a curative activity of 77.83% against rice sheath blight. This performance surpassed the commercial fungicide thifluzamide, which recorded 73.17% efficacy, while maintaining a favorable safety profile.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Yu PB et al. Discovery of acylhydrazide-modified usnic acid derivatives as novel antifungal agents: Design, synthesis, and preliminary mechanistic study. Pest Manag Sci. 2026 Apr 01. doi: 10.1002/ps.70773. PMID: 41922928.
Lucarini E et al. Discovery of semisynthetic derivatives of (R)- and (S)-usnic acids as potential antifungal agents against C. tropicalis and T. rubrum. RSC Med Chem. 2024. doi: 10.1039/d5md00457h.
Meena M et al. An Overview of the Alternaria Genus: Ecology, Pathogenicity and Importance for Agriculture and Human Health. Microorganisms. 2024. doi: 10.3390/microorganisms12010153.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers synthesized 40 novel usnic acid antifungal derivatives, identifying A24 as a potent agent that induces ROS accumulation to kill fungal pathogens...
5 months ago

A clinical comparison of extravascular and subcutaneous implantable cardioverter-defibrillators, detailing patient selection, pacing capabilities, and implantation nuances.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today